BWX Technologies, Inc. $BWXT Shares Sold by Levin Capital Strategies L.P.

Levin Capital Strategies L.P. lessened its holdings in shares of BWX Technologies, Inc. (NYSE:BWXT) by 3.0% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 98,629 shares of the technology company’s stock after selling 3,028 shares during the period. BWX Technologies accounts for approximately 1.5% of Levin Capital Strategies L.P.’s holdings, making the stock its 17th biggest position. Levin Capital Strategies L.P. owned 0.11% of BWX Technologies worth $20,169,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. WFA of San Diego LLC acquired a new position in BWX Technologies in the second quarter valued at approximately $29,000. MV Capital Management Inc. bought a new position in shares of BWX Technologies during the fourth quarter valued at approximately $32,000. Tucker Asset Management LLC acquired a new stake in shares of BWX Technologies during the 4th quarter worth approximately $36,000. ORG Partners LLC raised its position in shares of BWX Technologies by 143.2% during the 4th quarter. ORG Partners LLC now owns 231 shares of the technology company’s stock worth $40,000 after purchasing an additional 136 shares during the period. Finally, Vermillion Wealth Management Inc. raised its position in shares of BWX Technologies by 71.7% during the 4th quarter. Vermillion Wealth Management Inc. now owns 237 shares of the technology company’s stock worth $41,000 after purchasing an additional 99 shares during the period. Institutional investors and hedge funds own 94.39% of the company’s stock.

Insiders Place Their Bets

In related news, CEO Rex D. Geveden sold 10,000 shares of the stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $204.81, for a total value of $2,048,100.00. Following the completion of the transaction, the chief executive officer owned 202,491 shares in the company, valued at $41,472,181.71. This represents a 4.71% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Michael Thomas Fitzgerald sold 2,417 shares of the stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $209.25, for a total transaction of $505,757.25. Following the completion of the transaction, the chief financial officer owned 6,884 shares of the company’s stock, valued at $1,440,477. This represents a 25.99% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.60% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on BWXT. Bank of America boosted their price objective on BWX Technologies from $230.00 to $250.00 and gave the company a “buy” rating in a research report on Wednesday, March 25th. Zacks Research lowered BWX Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, May 11th. Deutsche Bank Aktiengesellschaft upgraded BWX Technologies from a “hold” rating to a “buy” rating and raised their target price for the company from $205.00 to $255.00 in a research note on Friday, May 15th. Wells Fargo & Company assumed coverage on shares of BWX Technologies in a report on Wednesday, April 1st. They set an “underweight” rating and a $200.00 price target for the company. Finally, Seaport Research Partners upgraded shares of BWX Technologies from a “neutral” rating to a “buy” rating and set a $245.00 price target for the company in a research report on Monday, June 22nd. Two analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $228.00.

BWX Technologies Stock Performance

Shares of NYSE BWXT opened at $174.74 on Thursday. The company has a current ratio of 2.40, a quick ratio of 2.33 and a debt-to-equity ratio of 1.58. The stock has a 50 day simple moving average of $192.72 and a 200-day simple moving average of $202.98. The company has a market cap of $16.01 billion, a PE ratio of 46.72, a P/E/G ratio of 2.95 and a beta of 0.74. BWX Technologies, Inc. has a 12-month low of $140.98 and a 12-month high of $241.82.

BWX Technologies (NYSE:BWXT) last posted its earnings results on Monday, May 4th. The technology company reported $1.12 EPS for the quarter, beating the consensus estimate of $0.92 by $0.20. The firm had revenue of $860.22 million for the quarter, compared to analysts’ expectations of $837.47 million. BWX Technologies had a return on equity of 31.33% and a net margin of 10.20%.The firm’s revenue was up 26.1% compared to the same quarter last year. During the same period last year, the firm earned $0.91 EPS. BWX Technologies has set its FY 2026 guidance at 4.600-4.750 EPS. On average, equities research analysts forecast that BWX Technologies, Inc. will post 4.6 EPS for the current year.

BWX Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, June 5th. Stockholders of record on Tuesday, May 19th were paid a $0.27 dividend. The ex-dividend date of this dividend was Tuesday, May 19th. This represents a $1.08 annualized dividend and a dividend yield of 0.6%. BWX Technologies’s dividend payout ratio is presently 28.88%.

About BWX Technologies

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.